PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New enzyme-replacement therapy shows promise for genetic lipid disease treatment

First-of-its-kind therapy, Sebelipase Alfa, has potential to effectively treat Lysosomal Acid Lipase Deficiency

2015-09-10
(Press-News.org) PHILADELPHIA--Of the more than 50 known lysosomal storage diseases (LSDs)-rare inherited metabolic disorders-only seven can be treated with approved enzyme-replacement therapies. Lysosomal acid lipase deficiency (LALD) is an LSD that causes fatty liver disease and cirrhosis. There is no treatment for the disease, which afflicts 1- 40,000 - 1 in 300,000 people across the world. In this week's New England Journal of Medicine, researchers report results of a trial showing the efficacy of a new enzyme-replacement therapy for LALD. In an accompanying editorial, Daniel J. Rader, MD, chair of the department of Genetics in the Perelman School of Medicine at the University of Pennsylvania, notes that this first-ever hepatocyte-targeting therapy will be pivotal in treating this disease.

In a phase 3 trial in patients with lysosomal acid lipase deficiency, researchers evaluated the safety and effectiveness of the hepatocyte-targeting enzyme-replacement therapy for LALD, known as sebelipase alfa. The therapy works by administering enzymes that specifically target hepatocytes, cells that make up nearly 80 percent of the liver. These enzymes are taken up by the hepatocytes, directed to the lysosomes, and replace the missing lysosomal acid lipase enzymes. With 66 patients involved in the 20-week trial, researchers found that treatment with sebelipase alfa resulted in reduced disease-related liver and blood cholesterol abnormalities, such as cirrhosis, hepatomegaly, and liver fibrosis. More, patients experienced lower cholesterol levels, and reduced liver fat content and size with continued treatment.

"LALD is an underdiagnosed disease with serious medical consequences," Rader said. "Sebelipase alfa could be a game-changer in the treatment of this disease. However, to effectively treat patients, physicians need to think of diagnosing this disorder and initiating this therapy, once available, as early as possible."

Rader also notes that while a larger, longer-term study is needed to prove that this treatment will prevent serious liver consequences, he says "sebelipase alfa has shown great potential for effectively treating and managing this underappreciated genetic lipid disorder."

INFORMATION:

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.



ELSE PRESS RELEASES FROM THIS DATE:

Study defines clinical trials likely to exclude patients with brain metastases

2015-09-09
Non-small cell lung cancer frequently spreads to the central nervous system (CNS), but patients with CNS metastases may be excluded from clinical trials of new drugs. A University of Colorado Cancer Center study being presented at the 16th World Conference on Lung Cancer reveals the full extent to which the CNS may be under-explored in clinical research. The study combed the website ClinicalTrials.gov to identify 413 open lung cancer clinical trials. Overall, 41 percent of trials only included patients if their CNS disease was previously treated. Twenty-six percent allowed ...

A new marker for migraine?

2015-09-09
MINNEAPOLIS - Researchers may have discovered a new marker found in the blood for episodic migraine, according to a study published in the September 9, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology. Episodic migraine is defined as having less than 15 headaches per month. "While more research is needed to confirm these initial findings, the possibility of discovering a new biomarker for migraine is exciting," said study author B. Lee Peterlin, DO, with the Johns Hopkins University School of Medicine in Baltimore and a member ...

Patients prefer relief from lower back pain over improved mobility

2015-09-09
A new study out today in the journal Neurology examines the question of quality of life for individuals with a common form of lower back pain called lumbar spinal stenosis. The findings show that, when asked to choose between treatments that reduced pain or would help them stand or walk, patients overwhelmingly chose pain relief. "There has long been a debate in the medical community over striking the right balance between pain relief and physical function," said John Markman, M.D., director of the Translational Pain Research Program in the University of Rochester ...

Last chance for oasis in China's desert

Last chance for oasis in Chinas desert
2015-09-09
This news release is available in German. Ten percent of the world's cotton is produced in the Xinjiang region in northwestern China. Irrigating the cotton fields, however, is causing ecological problems. After many years of research, a team of international researchers headed by Prof. Markus Disse at the Technical University of Munich (TUM) has developed a set of recommendations aimed at preserving the local environment. The Tarim basin in the Xinjiang region of northwestern China is unique. No other natural landscape is located as far from the ocean. It has ...

Discrimination during adolescence has lasting effect on body

2015-09-09
EVANSTON, Ill. --- In both blacks and whites, everyday feelings of discrimination can mess with the body's levels of the primary stress hormone, cortisol, new research suggests. In African-Americans, however, the negative effects of perceived discrimination on cortisol are stronger than in whites, according to the study, one of the first to look at the biological response to the cumulative impact of prejudicial treatment. The team of researchers, led by Northwestern University, also found that the teenage years are a particularly sensitive period to be experiencing ...

Can black Republicans win black votes? Not likely, UC study finds

2015-09-09
Are black voters more likely to vote for black candidates, regardless of political party affiliation? A new study by a University of Cincinnati researcher presents discouraging news for Republican leaders hoping to win over this Democratic stronghold by nominating black Republican candidates for political offices. "There are some very successful African-American Republicans, but those folks don't attract African-American votes," said the study's author, David Niven, a University of Cincinnati professor of political science. "Party matters so much more than race." In ...

Michigan 'See You in 7' program helps reduce heart failure readmissions

2015-09-09
Michigan hospitals participating in the American College of Cardiology's "See You in 7" program demonstrated important reductions in 30-day readmission rates for Medicare heart failure patients when compared to non-participating hospitals despite only modest increases in seven-day follow-up appointments, according to a study today in JACC: Heart Failure. "See You in 7" is part of the ACC's Hospital-to-Home initiative, a national quality improvement program aimed at reducing heart disease-related hospital readmissions and improving the transition from hospital to home. ...

Bats may use bidirectional echolocation to detect prey, orient themselves

Bats may use bidirectional echolocation to detect prey, orient themselves
2015-09-09
The barbastelle bat may emit two different types of weak echolocation signals alternately, one upward through the nose and one downward through the mouth, to find prey while undetected and to sufficiently keep track of the environment, respectively, according to a study published September 9, 2015 in the open-access journal PLOS ONE by Anna-Maria Seibert and colleagues from the University of Tübingen, Germany. Barbastelle bats prey almost exclusively on eared moths, using "stealth echolocation" signals that are 10-100 times weaker than those of other aerial hawking ...

UQ scientists close in on first dengue treatment

UQ scientists close in on first dengue treatment
2015-09-09
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists. UQ's School of Chemistry and Molecular Biosciences Head Professor Paul Young said the researchers had identified similarities in how the body reacted to dengue virus and bacterial infections, in a finding that would allow them to re-purpose existing drugs. "We have discovered that the dengue virus NS1 protein acts as a toxin in the body, in a similar manner to the way bacterial cell wall products lead to septic shock in bacterial infections," ...

NFL fans and ESPN reporters overly optimistic about team prospects

2015-09-09
US fans of the National Football League (NFL) and sports reporters assigned to specific teams have unrealistic expectations about how well their team will perform, finds new research from UCL and Oxford University. The study, published in PLOS ONE, also reveals which teams are most liked and disliked, as well as which teams have the most optimistic fans. The main results are from an April 2015 survey of 1,116 US-based NFL fans, who were asked to predict how many games their favourite and least favourite teams would win in the 2015 season. As each team plays 16 games ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New enzyme-replacement therapy shows promise for genetic lipid disease treatment
First-of-its-kind therapy, Sebelipase Alfa, has potential to effectively treat Lysosomal Acid Lipase Deficiency